Effects of 5-Aza-2′-deoxycytidine on the methylation state and function of the WWOX gene in the HO-8910 ovarian cancer cell line

被引:18
作者
Yan, Hongchao [1 ]
Yu, Nan [1 ]
Tong, Jianye [1 ]
机构
[1] Xuzhou Med Coll, Dept Obstet & Gynecol, Affiliated Hosp, Xuzhou 221002, Jiangsu, Peoples R China
关键词
ovarian cancer; WWOX gene; 5-Aza-2 '-deoxycytidine; DNA METHYLATION; BREAST-CANCER; CARCINOMA; DIAGNOSIS; TUMOR; EXPRESSION;
D O I
10.3892/ol.2013.1438
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to explore the effects of 5-Aza-2'-deoxycytidine (5-Aza-CdR), a DNA methylation inhibitor, on the methylation state and function of the WWOX gene in the HO-8910 ovarian cancer cell line. The HO-8910 cells were divided into two groups, a control group and a 5-Aza-CdR-treated group. The methylation state of the WWOX gene was evaluated using a methylation-specific PCR assay. The effect of 5-Aza-CdR on the HO-8910 cells was analyzed using MTT and cell invasion assays, as well as flow cytometry. The animal models were established by intraperitoneal transplantation of the cells into nude mice. Following treatment with 5-Aza-CdR, a demethylation state was detected in the HO-8910 cells. WWOX protein expression was significantly higher in the 5-Aza-CdR-treated group compared with that in the control group. The cell growth rate at each tested time point and the number of invasive cells were lower in the 5-Aza-CdR-treated group compared with that in the control group. Flow cytometry revealed that 67.13% of the cells were arrested at the G(0)/G(1) stage in the 5-Aza-CdR-treated group. The tumorigenic ability of the 5-Aza-CdR-treated group was lower compared with that of the control group. In conclusion, the methylation state of the WWOX gene in HO-8910 cells may be reversed using 5-Aza-CdR, which may also inhibit the growth of these cells.
引用
收藏
页码:845 / 849
页数:5
相关论文
共 16 条
[1]   DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatment [J].
Barton, Caroline A. ;
Hacker, Neville F. ;
Clark, Susan. J. ;
O'Brien, Philippa A. .
GYNECOLOGIC ONCOLOGY, 2008, 109 (01) :129-139
[2]  
Bednarek AK, 2000, CANCER RES, V60, P2140
[3]   DNA methylation and cancer diagnosis: new methods and applications [J].
Dehan, Pierre ;
Kustermans, Gaelle ;
Guenin, Samuel ;
Horion, Julie ;
Boniver, Jacques ;
Delvenne, Philippe .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2009, 9 (07) :651-657
[4]   WWOX: Its Genomics, Partners, and Functions [J].
Del Mare, Sara ;
Salah, Zaidoun ;
Aqeilan, Rami I. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 108 (04) :737-745
[5]   DNA methylation and the functional organization of the nuclear compartment [J].
Espadaa, Jesus ;
Esteller, Manel .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2010, 21 (02) :238-246
[6]   DNA Hypermethylation of ESR1 and PGR in Breast Cancer: Pathologic and Epidemiologic Associations [J].
Gaudet, Mia M. ;
Campan, Mihaela ;
Figueroa, Jonine D. ;
Yang, Xiaohong R. ;
Lissowska, Jolanta ;
Peplonska, Beata ;
Brinton, Louise A. ;
Rimm, David L. ;
Laird, Peter W. ;
Garcia-Closas, Montserrat ;
Sherman, Mark E. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (11) :3036-3043
[7]   DNA Methylation Profiles of Ovarian Epithelial Carcinoma Tumors and Cell Lines [J].
Houshdaran, Sahar ;
Hawley, Sarah ;
Palmer, Chana ;
Campan, Mihaela ;
Olsen, Mari N. ;
Ventura, Aviva P. ;
Knudsen, Beatrice S. ;
Drescher, Charles W. ;
Urban, Nicole D. ;
Brown, Patrick O. ;
Laird, Peter W. .
PLOS ONE, 2010, 5 (02)
[8]   Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India [J].
Kiran, Manjula ;
Chawla, Yogesh K. ;
Kaur, Jyotdeep .
CANCER GENETICS AND CYTOGENETICS, 2009, 195 (02) :112-119
[9]   Insulin Gene Expression Is Regulated by DNA Methylation [J].
Kuroda, Akio ;
Rauch, Tibor A. ;
Todorov, Ivan ;
Ku, Hsun Teresa ;
Al-Abdullah, Ismail H. ;
Kandeel, Fouad ;
Mullen, Yoko ;
Pfeifer, Gerd P. ;
Ferreri, Kevin .
PLOS ONE, 2009, 4 (09)
[10]   DNA methylation in cancer development, diagnosis and therapy-multiple opportunities for genotoxic agents to act as methylome disruptors or remediators [J].
Lewandowska, Joanna ;
Bartoszek, Agnieszka .
MUTAGENESIS, 2011, 26 (04) :475-487